On October 11, Vice Governor Fang Wei met with Eli Lilly and Company's Global Executive Vice President and President of International Business Unit, Ilya Joffa, at the provincial government. Fang Wei welcomed the guest's visit and congratulated the launch of Lilly's Suzhou capacity upgrade project. He said that we are participants in China's reform and opening up, and you are also participants. This year marks the 30th anniversary of the development and construction of Suzhou Industrial Park. Since Lilly Suzhou Pharmaceuticals settled in the park at the beginning of its development, it has continued to innovate and create, grow and expand, and made positive contributions to Jiangsu's industrial upgrading and opening up to the outside world. The biomedical industry is a key strategic emerging industry in our province, which is related to people's well-being and economic development. We hope that Lilly will continue to cultivate Jiangsu, give full play to its global brand resources and R&D advantages, actively participate in the construction of the biopharmaceutical industry chain, supply chain and innovation chain in our province, and facilitate the landing of more high-end projects to achieve higher levels of mutual benefit and win-win results, so as to build up the momentum for the next 30 years of the glory of the Suzhou Industrial Park. We will create a market-oriented, rule-of-law, internationalized and first-class business environment, and do a good job of serving and guaranteeing the investment and operation of the majority of foreign-funded enterprises in Suzhou. Mr. Ilya Yufa thanked Jiangsu for its long term support to Lilly Suzhou Pharmaceuticals, and expressed his confidence in the development of Jiangsu. Lilly will further strengthen the deep cooperation with Jiangsu and provide more quality products and services to the Chinese market.
